Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_assertion type Assertion NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_head.
- NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_assertion description "[Aberrant expression of CD2, CD3, and/or CD5 antigens was noted in 3 of 6 (50%) cases of patch/plaque-stage MF, all three cases of tumor-stage MF, and 5 of 8 (62%) pleomorphic CTCLs, but not in any of the 11 pseudo-T-cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_provenance.
- NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_assertion evidence source_evidence_literature NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_provenance.
- NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_assertion SIO_000772 9176388 NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_provenance.
- NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_assertion wasDerivedFrom befree-20140225 NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_provenance.
- NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_assertion wasGeneratedBy ECO_0000203 NP584834.RAkkWl2t4IYELwINyqbIQ1B-9dHwiIpsSpaJ9xs7R83W8130_provenance.